Home / Resources / Preclinical resources

前臨床

注目コンテンツ

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

ポスター

Upcoming preclinical webinars

ウェビナー

Transform Your PK/PD Workflow with AI and the Cloud

2025年7月10日 – 11am ET

ウェビナー

Phoenix NLME & Pirana：合理化されたファーマコメトリクスワークフロー用の強力なpopPKモデリングソフトウェア

Jul 15, Oct 7, Dec 16 – 11am ET

ウェビナー

【サターラSimcyp PBBMオンライン講座】～PBBMを一から学ぶ～第2回薬物吸収モデルとは？

2025年7月17日 – 10-11:30am, Japan Time

Latest preclinical blogs

All Preclinical - Blog

Blog

PBPKモデル化による生物学的同等性評価およびジェネリック医薬品承認の支援

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois

展示会・学会

ACoP 2025

October 18 - 21, 2025

展示会・学会

American College of Toxicology 2025 Annual Meeting

November 16 - 19, 2025 – Phoenix, Arizona – Booth 717

All preclinical resources

Pirana Tips and Tricks – Report Object Generation in Pirana

サターラの製品、ウェビナー

The Reference-scaled Average Bioequivalence (RSABE) Approach

Certara Products, Certara Products - Phoenix, Modeling and Simulation - PK/PD, Blog

The Medicine Maker: The Biosimulation Generation

Certara Services, Clinical Trials, Drug Development, Drug Safety, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation – PK/PD, Modeling and Simulation – QSP, Press Coverage

How Model-informed drug development rescue projects from a risky situation

Certara Services, Clinical Pharmacology, Homepage Latest, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Case Study

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

Modeling and Simulation - QSP, Poster

QSP Modeling in Cancer Therapy | Advancing Tumor-Selective Treatments

Modeling and Simulation - QSP, Poster

A minimal physiologically-based pharmacokinetic/pharmacodynamic mouse xenograft model to inform the evaluation of 212Pb-based Radio-DARPins targeting DLL3

Modeling and Simulation - QSP, Poster

A Quantitative Systems Pharmacology Model to Investigate the Crucial Role of Epithelial Damage in the Pathogenesis of Inflammatory Bowel Disease

Modeling and Simulation - QSP, Poster

EACPT 2025 CONGRESS

Conference - Early Clinical LP, Conference - Preclinical LP, Conference LP - Latest, Drug-Drug Interactions (DDI), Conference

On-Demand Webinar: Streamlining Population PK Modeling with Phoenix NLME and Pirana

Certara Products - Phoenix, On-Demand Webinar

Transform Your PK/PD Workflow with AI and the Cloud

Certara Products - Phoenix, Webinar - Resources LP - Upcoming, Webinar

Accelerate IVIVC Modeling: How Formulation Scientists Can Save Time and Reduce Clinical Study Burden

Certara Products - Phoenix, Webinar

ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。

前臨床

最新のリソース

The Reference-scaled Average Bioequivalence (RSABE) Approach

The Medicine Maker: The Biosimulation Generation

How Model-informed drug development rescue projects from a risky situation

注目コンテンツ

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

Upcoming preclinical webinars

Transform Your PK/PD Workflow with AI and the Cloud

Phoenix NLME & Pirana：合理化されたファーマコメトリクスワークフロー用の強力なpopPKモデリングソフトウェア

【サターラSimcyp PBBMオンライン講座】～PBBMを一から学ぶ～第2回薬物吸収モデルとは？

Latest preclinical blogs

医薬品開発におけるPK/PDモデリングのための機械学習

米国FDAのモデルに基づく医薬品開発と対になったパイロットプログラムが治験依頼者を助ける方法

Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis

指標となる臨床的薬剤相互作用研究における代謝物の測定

Key development considerations for cell therapies

PBPKモデル化による生物学的同等性評価およびジェネリック医薬品承認の支援

以下のイベントで弊社のエキスパートをご紹介

ISSX 2025 International Meeting

ACoP 2025

American College of Toxicology 2025 Annual Meeting

All preclinical resources

Pirana Tips and Tricks – Report Object Generation in Pirana

The Reference-scaled Average Bioequivalence (RSABE) Approach

The Medicine Maker: The Biosimulation Generation

How Model-informed drug development rescue projects from a risky situation

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

QSP Modeling in Cancer Therapy | Advancing Tumor-Selective Treatments

A minimal physiologically-based pharmacokinetic/pharmacodynamic mouse xenograft model to inform the evaluation of 212Pb-based Radio-DARPins targeting DLL3

A Quantitative Systems Pharmacology Model to Investigate the Crucial Role of Epithelial Damage in the Pathogenesis of Inflammatory Bowel Disease

EACPT 2025 CONGRESS

On-Demand Webinar: Streamlining Population PK Modeling with Phoenix NLME and Pirana

Transform Your PK/PD Workflow with AI and the Cloud

Accelerate IVIVC Modeling: How Formulation Scientists Can Save Time and Reduce Clinical Study Burden

メルマガ登録

クイックアクセス

ソリューション

お問合せ